Identification of non-covalent 3C-like protease inhibitors against severe acute respiratory syndrome coronavirus-2 via virtual screening of a Korean compound library

The outbreak of coronavirus (CoV) disease 2019 (COVID-19) caused by the severe acute respiratory syndrome CoV-2 (SARS-CoV-2) has turned into a pandemic. The enzyme 3C-like protease (3CL(pro)) is essential for the maturation of viral polyproteins in SARS-CoV-2 and is therefore regarded as a key drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Joo-Youn, Kuo, Chih-Jung, Shin, Jin Soo, Jung, Eunhye, Liang, Po-Huang, Jung, Young-Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091729/
https://www.ncbi.nlm.nih.gov/pubmed/33957246
http://dx.doi.org/10.1016/j.bmcl.2021.128067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091729/
https://www.ncbi.nlm.nih.gov/pubmed/33957246
http://dx.doi.org/10.1016/j.bmcl.2021.128067

Ejemplares similares